Endogenous PCSK9 may influence circulating CD45(neg)/CD34(bright) and CD45(neg)/CD34(bright)/CD146(neg) cells in patients with type 2 diabetes mellitus

Protease proprotein convertase subtilisin/kexin type 9 (PCSK9) is a regulator of LDL cholesterol clearance and has been associated with cardiovascular risk. PCSK9 inhibitors increase in vivo circulating endothelial progenitor cells (EPCs), a subtype of immature cells involved in ongoing endothelial...

Descripción completa

Detalles Bibliográficos
Autores principales: Tripaldi, Romina, Lanuti, Paola, Simeone, Paola Giustina, Liani, Rossella, Bologna, Giuseppina, Ciotti, Sonia, Simeone, Pasquale, Di Castelnuovo, Augusto, Marchisio, Marco, Cipollone, Francesco, Santilli, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102605/
https://www.ncbi.nlm.nih.gov/pubmed/33958634
http://dx.doi.org/10.1038/s41598-021-88941-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102605/
https://www.ncbi.nlm.nih.gov/pubmed/33958634
http://dx.doi.org/10.1038/s41598-021-88941-x

Ejemplares similares